After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Edwards Lifesciences Corp (EW) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$2.52, or -3.85%, to $63.01. The Edwards Lifesciences Corp has recorded 108,165 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION.
EW belongs to the Healthcare sector of the NYSE while operating in the Medical Devices industry. At the end of the last regular session, the stock closed at $65.53 and fluctuated between $65.73 as its day high and $64.07 as its day low. The current market capitalization of Edwards Lifesciences Corp is $39.74B. A total of 3.81 million shares were traded on the day, compared to an average of 3.93M shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, EW has seen 15 BUY and 17 SELL insider trades, representing the acquisition of 210,669 and the disposition of 208,210 shares. Over the last 12 months, there were 92 BUYs and 118 SELLs from insiders. Insiders purchased 1,127,257 shares during that period but sold 956,974.
In the most recent transaction, Ullem Scott B. sold 7,255 shares of EW for 62.66 per share on Oct 31. After the transaction, the CVP, Chief Financial Officer now owns 19,248 company shares. In a previous transaction on Oct 13, Wood Larry L sold 8,660 shares at 70.00 per share. EW shares that Global President TAVR & Surg owns now total 213,794.
Among the insiders who sold shares, BOBO DONALD E JR disposed of 5,000 shares on Oct 13 at a per-share price of $69.98. This resulted in the CVP,Strategy/Corp Development holding 39,503 shares of EW after the transaction. In another insider transaction, Szyman Catherine M. sold 5,000 shares at $72.68 per share on Oct 10. Company shares held by the CVP, Critical Care now total 34,814.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for EW in the last 3 months, the mean price target is $80.66 with high estimates of $102.00 and low estimates of $63.00. In terms of 52-week highs and lows, EW has a high of $94.87 and a low of $60.57.
As of this writing, EW has an earnings estimate of $Estee Lauder Companies, Inc. (T per share for the current quarter. EPS was calculated based on a consensus of WeWork Inc. estimates, with a high estimate of $Wayfair Inc. per share and a lower estimate of $Energy Transfer LP.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. EW’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $690.30M in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $10.98, while its Total Shareholder’s Equity was $5.84B.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EW is Buy with a score of 4.10.